SJOGREN'S SYNDROME (SS)
Clinical trials for SJOGREN'S SYNDROME (SS) explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME (SS) trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME (SS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Shot gene therapy tested to halt devastating autoimmune attacks
Disease control Recruiting nowThis early-stage study is testing a new, one-time treatment called TI-0032-III for people with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard drugs. The treatment uses an injection to genetically reprogram the patient's own immune cells …
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New cell therapy tested for patients Who've tried everything else
Disease control Recruiting nowThis is an early safety study testing a single infusion of a new cell therapy called YTS109. It aims to see if the treatment is safe and shows any signs of helping adults with severe autoimmune diseases that have not responded to standard treatments. The study will enroll about 1…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC